Cost-effectiveness of an early intervention service for people with psychosis.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 20435964.
- Also identified by DOI 10.1192/bjp.bp.109.065896.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There is concern that delaying treatment for psychosis may have a negative impact on its long-term course. A number of countries have developed early intervention teams but there is limited evidence regarding their cost-effectiveness. To compare the costs and cost-effectiveness of an early intervention service in London with standard care. Individuals in their first episode of psychosis (or those who had previously discontinued treatment) were recruited to the study. Clinical variables and costs were measured at baseline and then at 6- and 18-month follow-up. Information on quality of life and vocational outcomes were combined with costs to assess cost-effectiveness. A total of 144 people were randomised. Total mean costs were 11,685 pounds sterling in the early intervention group and 14,062 pounds sterling in the standard care group, with the difference not being significant (95% CI -8128 pounds sterling to 3326 pounds sterling). When costs were combined with improved vocational and quality of life outcomes it was shown that early intervention would have a very high likelihood of being cost-effective. Early intervention did not increase costs and was highly likely to be cost-effective when compared with standard care.
Medical subject headings
- Community Mental Health Services
- Delivery of Health Care
- Health Care Costs
- Psychotic Disorders